Derivative Instruments and Hedging Activities - Derivatives in Statements of Operations (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	May 02, 2021	Apr. 26, 2020	May 02, 2021	Apr. 26, 2020
Derivative Instruments, Gain (Loss) [Line Items]
Net Sales	$ 5,582	$ 3,957	$ 10,744	$ 8,119
Cost of products sold	2,929	2,208	5,742	4,512
Research, development and engineering	617	550	1,223	1,102
Interest expense	61	61	122	120
Amount of Gain or (Loss) Reclassified from AOCI into Consolidated Condensed Statement of Operations	(5)	(2)	(9)	(1)
Amount of Gain (Loss) Excluded from Effectiveness Testing Recognized in Consolidated Condensed Statement of Operations	0	0	(1)	2
Foreign exchange contracts | Sales
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain or (Loss) Reclassified from AOCI into Consolidated Condensed Statement of Operations	(1)	2	(5)	1
Amount of Gain (Loss) Excluded from Effectiveness Testing Recognized in Consolidated Condensed Statement of Operations	0	1	0	3
Foreign exchange contracts | Cost of products sold
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain or (Loss) Reclassified from AOCI into Consolidated Condensed Statement of Operations	(2)	(3)	0	(1)
Amount of Gain (Loss) Excluded from Effectiveness Testing Recognized in Consolidated Condensed Statement of Operations	0	(1)	(1)	(1)
Foreign exchange contracts | Research, development and engineering
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain or (Loss) Reclassified from AOCI into Consolidated Condensed Statement of Operations	1	(1)	2	0
Amount of Gain (Loss) Excluded from Effectiveness Testing Recognized in Consolidated Condensed Statement of Operations	0	0	0	0
Interest rate contracts | Interest expense
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain or (Loss) Reclassified from AOCI into Consolidated Condensed Statement of Operations	(3)	0	(6)	(1)
Amount of Gain (Loss) Excluded from Effectiveness Testing Recognized in Consolidated Condensed Statement of Operations	$ 0	$ 0	$ 0	$ 0